Comparison of the SCOPE and LIFE results [2] (multiple letters)

Journal of Hypertension

Volumn 21, Issue 9, 2003, Pages 1772-1773

  Kjeldsen, Sverre E ^a   Dahlöf, Björn ^b   Devereux, Richard B ^g   Lindholm, Lars H ^g   Nieminen, Markku S ^c   Oparil, Suzanne ^d   Wedel, Hans ^e   Lithell, Hans ^f  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^f UPPSALA UNIVERSITY   (Sweden)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; LOSARTAN; PLACEBO; THIAZIDE DIURETIC AGENT; URIC ACID;

ADD ON THERAPY; ANTICOAGULATION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; LETTER; MAJOR CLINICAL STUDY; METHODOLOGY; MORTALITY; OPEN STUDY; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; STROKE; URIC ACID BLOOD LEVEL;

EID: 0041384307     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200309000-00030     Document Type: Letter

References (0)